More NewsRead More
RXi Pharmaceuticals to Present an Update on its Consumer Health Programs at the Society for Investigative Dermatology 75th Annual Meeting
May 04, 2016
RXi Pharmaceuticals and Thera Neuropharma Enter into an Exclusive License Agreement for RXi's Self-Delivering RNAi (sd-rxRNA®) Platform Targeting SOD1 to Develop Therapeutics for Neurodegenerative Dis
May 03, 2016
RXi Pharmaceuticals Announces Advancement of its Ophthalmology Franchise with Successful Topical Delivery of sd-rxRNA to the Cornea in an in vivo Corneal Wound Model
April 28, 2016
RXi Pharmaceuticals to Webcast First Quarter 2016 Financial Results on Thursday, May 12, 2016
April 27, 2016
RXi Pharmaceuticals Announces 'Biotech Spotlight' Presentation at the BioNetwork Partnering Summit
April 26, 2016
RXi Pharmaceuticals to Present at 18th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference
April 25, 2016
RXi Pharmaceuticals Fortifies its Novel RNAi Patent Portfolio with Notice of Allowance for Lead Clinical Candidate RXI-109
April 19, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here